If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Laura Carrassa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
trabectedin Medicine & Life Sciences
Mantle-Cell Lymphoma Medicine & Life Sciences
DNA Damage Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Cell Line Medicine & Life Sciences
Myxoid Liposarcoma Medicine & Life Sciences
pioglitazone Medicine & Life Sciences
gemcitabine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

Combination of PPARg agonist pioglitazone and trabectedin induce adipocyte differentiation to overcome trabectedin resistance in myxoid liposarcomas

Frapolli, R., Bello, E., Ponzo, M., Craparotta, I., Mannarino, L., Ballabio, S., Marchini, S., Carrassa, L., Ubezio, P., Porcu, L., Brich, S., Sanfilippo, R., Casali, P. G., Gronchi, A., Pilotti, S. & D'Incalci, M., Dec 15 2019, In : Clinical Cancer Research. 25, 24, p. 7565-7575 11 p.

Research output: Contribution to journalArticle

trabectedin
pioglitazone
Myxoid Liposarcoma
Adipocytes
Adipogenesis

Combination of PPARg agonist pioglitazone and trabectedin induce adipocyte differentiation to overcome trabectedin resistance in myxoid liposarcomas

Frapolli, R., Bello, E., Ponzo, M., Craparotta, I., Mannarino, L., Ballabio, S., Marchini, S., Carrassa, L., Ubezio, P., Porcu, L., Brich, S., Sanfilippo, R., Casali, P. G., Gronchi, A., Pilotti, S. & D'Incalci, M., Dec 15 2019, In : Clin. Cancer Res.. 25, 24, p. 7565-7575 11 p.

Research output: Contribution to journalArticle

Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin

Bello, E., Brich, S., Craparotta, I., Mannarino, L., Ballabio, S., Gatta, R., Marchini, S., Carrassa, L., Matteo, C., Sanfilippo, R., Gronchi, A., Casali, P. G., Pilotti, S., D’Incalci, M. & Frapolli, R., Sep 10 2019, In : British Journal of Cancer. 121, 6, p. 464-473 10 p.

Research output: Contribution to journalArticle

trabectedin
Myxoid Liposarcoma
Heterografts
Nude Mice
Therapeutics

Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin

Bello, E., Brich, S., Craparotta, I., Mannarino, L., Ballabio, S., Gatta, R., Marchini, S., Carrassa, L., Matteo, C., Sanfilippo, R., Gronchi, A., Casali, P. G., Pilotti, S., D’Incalci, M. & Frapolli, R., Sep 10 2019, In : British Journal of Cancer. 121, 6, p. 464-473 10 p.

Research output: Contribution to journalArticle

The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents

Spriano, F., Chung, E. Y. L., Gaudio, E., Tarantelli, C., Cascione, L., Napoli, S., Jessen, K., Carrassa, L., Priebe, V., Sartori, G., Graham, G., Selvanathan, S. P., Cavalli, A., Rinaldi, A., Kwee, I., Testoni, M., Genini, D., Ye, B. H., Zucca, E., Stathis, A. & 3 others, Lannutti, B., Toretsky, J. A. & Bertoni, F., Aug 15 2019, In : Clin. Cancer Res.. 25, 16, p. 5167-5176 10 p.

Research output: Contribution to journalArticle

Lymphoma
Transcription Factors
Lymphoma, Large B-Cell, Diffuse
B-Lymphocytes
RNA Helicases